Other ingredients
Dicalcium Phosphate (DCP); Hypromellose; Microcrystalline Cellulose; Magnesium Stearate (Mg Stearate); Croscarmellose Sodium; Silicon Dioxide (SiO2); Stearic Acid
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
Safrel
Potassium Iodide 130 mg
Tablet or Pill
Serving size2 Tablet(s)
Servings per containerNot listed
Package240 Tablet(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 2 Tablet(s)
Potassium Iodide130 mgDV not established
Label directions
Suggested use: Take two (2) tablets daily; preferably with food.
Label warnings
Warning: Consult your doctor if you are pregnant nursing taking any medications or have a medical condition. Keep out of reach of children. Do not use if seal under cap is broken or missing. For short-term use
Identity and label version
NIH label record328950
Entered into NIH DSLDMay 21, 2025
UPC / GTIN00371309000122
Manufacturer / distributor on labelSafrel Pharmaceuticals
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (1)
Current labelNIH record 328950Entered May 21, 2025
Potassium Iodide130 mg
Label warning: Warning: Consult your doctor if you are pregnant nursing taking any medications or have a medical condition. Keep out of reach of children. Do not use if seal under cap is broken or missing. For short-term use
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
More from Safrel
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.